What are the breastfeeding restrictions during and after brolucizumab treatment?

Brolucizumab is not recommended during breastfeeding, breastfeeding should not start for at least one month after the last dose when stopping treatment, and the decision to discontinue breastfeeding or abstain from therapy must weigh the benefits for the child and woman.